AI assistant

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

Pluri Inc. Director's Dealing 2011

Jan 13, 2011

6990_dirs_2011-01-13_ccada33f-1aa7-4cdb-bb8b-9f9678e024c6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: PLURISTEM THERAPEUTICS INC (PSTI)
CIK: 0001158780
Period of Report: 2011-01-11

Reporting Person: Aberman Zami (Director, CEO & Chairman)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2011-01-11	Common Stock	S	25000	$2.60	Disposed	874151	Direct

Footnotes

F1: The sales reported on this Form 4 were effected pursuant to automatic selling under Rule 10b5-1 trading plan adopted by the reporting person on June 10, 2010.